RxDoctor Payments Data

Jun Kim, DO

Adult Reconstructive Orthopaedic Surgery · Visalia, CANPI 1841638699

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (57.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 60.6% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $12,303 and has fallen 94.4% since, to $688 in 2025.

$18,846in general payments, 2019–2025

Across 114 payments — averaging $165.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$11K
  • Zimmer Biomet$5K
  • Stryker$1K
  • Sequoia Surgical, Inc.$561
  • Medical Device Business Services, Inc.$329
  • Johnson & Johnson$191
  • plus $593 from 17 others

What the payments were for

  • Travel & lodging$4,71125%
  • Food & beverage$3,23717%
  • Education$10,89858%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,846 in reported general payments places this provider in the 60th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$170,814
Medicare patients
441
Services billed
1,469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib164$4,273
Oxycodone Hcl276$1,231
Gabapentin157$676
Cefadroxil82$508
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen54$483
Diclofenac Sodium28$393
Cephalexin21$272
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$175
Tramadol Hcl47$93
Acetaminophen-CodeineAcetaminophen With Codeine16$86
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$62
Meloxicam27$35
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$19

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Visalia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →